









市場行情
/
股票
/
nasdaq-gkos
/

Glaukos Corp

GKOS

116.220USD

-0.420-0.36%

收盤 12/26, 16:00（美東）報價延遲15分鐘

6.67B總市值

虧損本益比TTM



Glaukos Corp

116.220

-0.420-0.36%

概覽公司財務分析

概覽

公司

財務

分析

關於 Glaukos Corp 公司

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Glaukos Corp簡介



公司代碼GKOS

公司名稱Glaukos Corp

上市日期Jun 25, 2015

CEOBurns (Thomas William)

員工數量995

證券類型Ordinary Share

年結日Jun 25

公司地址1 Glaukos Way

城市ALISO VIEJO

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編92656

電話19493679600

網址https://www.glaukos.com

公司代碼GKOS

上市日期Jun 25, 2015

CEOBurns (Thomas William)

Glaukos Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

Dr. Leana S. Wen, M.D.

Independent Director

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

Ms. Denice M. Torres, J.D.

Independent Director

Mr. Joseph E. Gilliam

President, Chief Operating Officer

名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

地區USD

名稱

營收

佔比

United States

90.52M

72.93%

International

33.60M

27.07%

業務

地區

業務USD

名稱

營收

佔比

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.50%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

其他

62.08%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.50%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

其他

62.08%

股東類型

持股股東

佔比

Investment Advisor

47.73%

Investment Advisor/Hedge Fund

35.27%

Hedge Fund

10.16%

Individual Investor

3.30%

Research Firm

2.10%

Pension Fund

2.09%

Bank and Trust

1.33%

Sovereign Wealth Fund

1.32%

Venture Capital

0.64%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

2023Q2

486

51.69M

106.83%

-2.99M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.90M

13.77%

+252.68K

+3.31%

Jun 30, 2025

The Vanguard Group, Inc.

6.10M

10.63%

+146.00K

+2.45%

Jun 30, 2025

Wellington Management Company, LLP

3.24M

5.66%

+953.61K

+41.63%

Jun 30, 2025

PRIMECAP Management Company

1.83M

3.19%

+609.52K

+50.02%

Jun 30, 2025

State Street Investment Management (US)

2.09M

3.64%

+105.97K

+5.34%

Jun 30, 2025

AllianceBernstein L.P.

1.25M

2.18%

-25.68K

-2.01%

Jun 30, 2025

Burns (Thomas William)

1.51M

2.63%

+10.26K

+0.69%

Sep 23, 2025

Geode Capital Management, L.L.C.

1.33M

2.32%

+115.53K

+9.51%

Jun 30, 2025

Columbia Threadneedle Investments (US)

1.02M

1.78%

+73.69K

+7.78%

Jun 30, 2025

Westfield Capital Management Company, L.P.

1.17M

2.04%

+83.67K

+7.72%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco S&P SmallCap Health Care ETF

3.09%

Alger Weatherbie Enduring Growth ETF

2.07%

State Street SPDR S&P Health Care Equipment ETF

1.79%

ROBO Global Healthcare Technology & Innovation ETF

1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.65%

iShares S&P Small-Cap 600 Growth ETF

0.64%

iShares U.S. Medical Devices ETF

0.6%

OneAscent Enhanced Small and Mid Cap ETF

0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

0.51%

Invesco S&P SmallCap Health Care ETF

佔比3.09%

Alger Weatherbie Enduring Growth ETF

佔比2.07%

State Street SPDR S&P Health Care Equipment ETF

佔比1.79%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

佔比0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

佔比0.65%

iShares S&P Small-Cap 600 Growth ETF

佔比0.64%

iShares U.S. Medical Devices ETF

佔比0.6%

OneAscent Enhanced Small and Mid Cap ETF

佔比0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

佔比0.51%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Glaukos Corp的前五大股東是誰？



Glaukos Corp的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：7.90M
佔總股份比例：13.77%。
The Vanguard Group, Inc.
持有股份：6.10M
佔總股份比例：10.63%。
Wellington Management Company, LLP
持有股份：3.24M
佔總股份比例：5.66%。
PRIMECAP Management Company
持有股份：1.83M
佔總股份比例：3.19%。
State Street Investment Management (US)
持有股份：2.09M
佔總股份比例：3.64%。